Oleuropein was demonstrated to be able to prevent the development of melanoma, colorectal, breast, and chronic myoid leukemia by suppressing the expression of GLUT1, MCT1 and PKM2 in the glycolysis pathway (Ruzzolini et al., 2020). The gene discussed is PKM; the disease is melanoma.